Samsung is collaborating with Stanford Medicine to improve Sleep Apnea Detection and Sleep Health by launching an innovative health solution.
The collaboration aims to introduce an innovative health solution based on Samsung’s obstructive sleep apnea feature, which has received the first-of-kind De Novo clearance from the U.S Food and Drug Administration (FDA).
A joint study by Professors Capasso and Kushida aims to improve Samsung’s Sleep Apnea feature using AI so that it can detect dial monitoring and management, enable timely interventions, and enhance sleep health.
The Galaxy Watch Sleep Apnea feature, which detects moderate to severe obstructive sleep apnea, has received regulatory clearance following approval from Korea’s Ministry of Food and Drug Safety (MFDS) in selected regions, including the US and Kora. Now, Samsung is looking forward to expanding this feature in Brazil and 29 more markets.
Reportedly, the Sleep Apnea feature will be expanded to additional countries around the world, enabling more people to proactively identify symptoms early and prevent further long-term complications of OSA.
Dr. Hon Pak, Senior Vice President and Head of the Digital Health Team, Mobile eXperience Business, Samsung Electronics, stated, “This collaboration with Stanford Medicine will combine our deep technology expertise with Stanford’s leading research capabilities to unlock new innovations in preventative care.”
Noticeably, the availability of the Sleep Apnea feature may vary by market, carrier, model, or paired smartphone. The Galaxy Watch 4 and all later models are compatible with this feature. The basic requirement for it is that the Galaxy Watch must have at least Wear OS 5.0 or above paired with a Galaxy smartphone running at least Android 12.
